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In cultured human myometrial cells application of caffeine (I-30 mM) did not result in an elevation of intracellular CaZf ([Ca”],). Caffeine was 
found to reversibly inhibit both spontaneous and agonist-induced repetitive rises in [Caz’li possibly as a consequence of its ability to interfere with 
the binding of inositol trisphosphate (IP,) to the receptor on the sarcoplasmic reticulum. Brief applications of ryanodine (I-1OpM) were observed 
to elevate [Ca’+l, and repeated exposures to ryanodine could elicit Ca2’ transients of similar magnitude. Ryanodine was also observed to mobilise 
Car’ in cells bathed in nominally Ca2’-free solution. These observations uggest he presence of a novel type of ryanodine-sensitive Ca2’-induced 
Ca*’ release (R-CICR) system in human myometrial cells. 
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1. INTRODUCTION 
The mechanisms which lead to a rise in Ca2+ in 
myometrial smooth muscle have been shown to include 
voltage and receptor operated influx pathways and the 
mobilisation of Ca2+ from intracellular stores [l]. The 
experiments described in this paper were carried out to 
identify the nature of the internal Ca2+ stores in cultured 
human myometrial smooth muscle cells using the phar- 
macological agents caffeine and ryanodine. 
In many smooth muscle cell types there appear to be 
two distinct intracellular stores of Ca2’, which may in- 
teract with each other to generate Ca2’ signals. One 
store can be activated by the methyxanthine caffeine to 
release Ca2+ and is sensitive to the plant alkaloid ryan- 
odine. The purified ryanodine receptor from the sarco- 
plasmic reticulum is a large molecular mass protein 
which associates as a homotetramer with a large con- 
ductance cation channel upon incorporation into planar 
lipid bilayers [2]. The morphology of the purified ryan- 
odine receptor is identical to the ‘feet’ structures first 
seen to span the transverse tubule-sarcoplasmic reticu- 
lum junction in striated muscle [3]. Expression studies 
suggest hat the large molecular weight ‘foot’ protein is 
the ryanodine receptor and sarcoplasmic reticulum Ca2+ 
release channel [4] and is sensitive to both caffeine and 
ryanodine. At low concentrations (nanomolar range), 
ryanodine will promote Ca” release while at high con- 
centrations (micromolar range) Ca2+ release is inhibited 
[5]. A second intracellular Ca2+ store can be activated 
by inositol trisphosphate (IPJ [6]. This mechanism is 
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inhibited by caffeine which interferes with the produc- 
tion of IP, [7& Roth stores can be activated by Ca” and 
consequently operate as Ca2’-induced Ca” release 
(CICR) systems. Therefore, these mechanisms may be 
referred to as the IP,-sensitive CICR (I-CICR) and the 
ryanodine-sensitive CICR (R-CICR) systems. 
2. MATERIALS AND METHODS 
Human myometrial tissue was obtained from patients with consent 
from the lower uterine segment from patients undergoing elective 
caesarean, section at term and from hysterectomy (patients under 40 
years of age). Ethical approval was granted by Newcastle Area Health 
Authority. Samples were immediately placed in culture medium 199 
(M199; 25 mM HEPES, without Na’ pyruvate and with 450 mg/l 
glucose, Gibco Ltd.). Myocytes were prepared by enzymatic disper- 
sion as previously described [S]. Cells were incubated for 1 h at 37°C 
with the Ca2+-sensitive fluorochrome Fura- in Ml99 containing 5pM 
of the acetoxy-methyl ester form of the dye. Cells were placed in a 
2OO@ bath on the stage of the microscope and solutions were perfused 
through the bath at 5-8 ml/min. Cells were superfused at 3437°C with 
a normal balanced salt solution containing (mM): 140 NaCl; 4.5 KCI; 
2.5 CaCl,; 1 MgCl,; 1 NaH,PO,; 5 glucose and 10 HEPES buffered 
to pH 7.4. Balanced salt solutions without Ca2+ were supplemented 
with 2OOpM EGTA and used as indicated in the results. Caffeine and 
oxytocin were obtained from Sigma Chemicals, Dot-set, UK. Rya- 
nodine (Lot No. 49626) was obtained from ICN Biochemicals, Cleve- 
land, Ohio. 
Fluorescence measurements were carried out using a cooled inte- 
grating charged coupled device. (CCD) imaging system (Newcastle 
Photometric Systems, Seaton Bum, Newcastle, UK). During an exper- 
iment the light intensity was measured at wavelengths greater than 
520 nm using excitation wavelengths of 350/380 nm and from this the 
wavelength intensity ratio was calculated. This ratio was displayed as 
a function of time for each experimental rea and used as an approx- 
imation of [Ca”], [9]. 
An extracellular calibration was carried out on the system using 
10 PM solutions of the penta-potassium salt of the dye in buffers of 
known Ca2’ concentration. This concentration gives fluorescence val- 
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ues similar to those obtained in dye-loaded cells. Calibration curves 
can be constructed from the ratio obtained for increasing free Ca’+ 
concentration. However, it must be noted that there are many prob- 
lems associated with the calibration of Fura- and it is generally 
accepted that this type of calibration cannot be used to estimate 
absolute ion concentrations in cells loaded with the ester form of the 
dye [lo]. Therefore, all results in this paper will be expressed in terms 
of fluorescence ratio changes only. 
3. RESULTS 
In an initial series of experiments cells were exposed 
to caffeine (l-30 mM) in a balanced salt solution (Fig. 
1A). Application of caffeine did not result in an increase 
in [Ca”],. Superfusing a cell with oxytocin (lo-’ M) led 
to the activation of a series of transient increases in 
[Ca2’],. These agonist-induced oscillations were found 
to be reversibly inhibited by caffeine (10-30 mM). Fig. 
1 B shows an example of the inhibition caused by 10 mM 
caffeine. Approximately 15% of myometrial cells in cul- 
ture demonstrate spontaneous oscillations in [Ca2’], [8]. 
Fig. 1C illustrates this type of Ca2’ activity and shows 
that these spontaneous oscillations were also inhibited 
by the addition of 10 mM caffeine to the bathing solu- 
tion. The absence of any Ca2+ mobilising action of caf- 
feine in these cells suggests that the CICR mechanism 
existing in myometrial cells differs from the caffeine- 
activated R-CICR systems found in skeletal and cardiac 
muscle and neural tissue. 
If the classical R-CICR system were to operate in 
these cells then ryanodine, which acts predominantly on 
the R-CICR system, should have no effect on [Ca2’],. 
However, when cells were exposed to ryanodine (l-10 
AM), in a normal balanced salt solution for 60-100 
seconds, a transient increase in [Ca2’], was observed. 
This effect occurred after a short delay of between 40- 
50 s and Ca2+ returned to resting levels after exposure 
(Fig. 2A). Several transient responses to ryanodine, all 
of similar amplitude, could be elicited in the same cell. 
Fig. 2B shows an example of an experiment o deter- 
mine the site of action of ryanodine. In cells washed in 
nominally Ca2+-free solution. ryanodine was still capa- 
ble of elevating [Ca’+]i. The transient increase in [Ca2’], 
was smaller in amplitude than responses een in Ca2’- 
containing solution and consistently exhibited an unre- 
solved double-peak response. Under these conditions 
the Ca2+ must be derived solely from intracellular 
stores, indicating that ryanodine is capable of modulat- 
ing the release of stored Ca2’. 
4. DISCUSSION 
The inhibitory effects of caffeine on agonist-induced 
generation of intracellular Ca2+ oscillations are well 
documented [11,12]. The mechanism by which caffeine 
exerts its inhibitory effect is thought to involve the sec- 
ond messenger IP,. Microinjection of IP,, in Xenopus 
oocytes, in the presence of caffeine failed to elevate 
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Fig. 1. (a) illustrates the lack of response to 10 mM caffeine on a single 
cultured human myometrial cell; (b) shows the inhibitory action of 
10 mM caffeine on Ca*’ oscillations induced by exposing the cells to 
10m9 M oxytocin; (c) demonstrates the inhibition of spontaneous oscil- 
lations in [Ca”], by the application of 10 mM caffeine. Application of 
caffeine and oxytocin to the bathing solution are indicated by the solid 
bars. Ordinates denote the ratio of fluorescence intensity measured at 
350/380 nm, abscissae show time in seconds. Temperature 34°C. 
[Ca2’]i suggesting that the inhibitory actions of caffeine 
were either at the level of IP, binding to the sarcoplas- 
mic reticulum or at the level of the subsequent release 
of Ca2’ [13]. In human myometrial smooth muscle cells 
it has been shown that oxytocin will elevate IP, [ 141 and 
it is suspected that IP, can mobilise Ca2’ from intracel- 
lular stores [6]. Since it is thought that caffeine inhibits 
the production of IP, [7], this mechanism may provide 
an explanation for the ability of caffeine to block the 
agonist-induced oscillations in intracellular Ca2+ seen in 
these cells. Spontaneous oscillations in [Ca”], are also 
inhibited by caffeine which may indicate an involvement 
of basal levels of IP, in their production. These observa- 
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Fig. 2. (a) shows the effect of repeated brief applications of 1 ,uM 
ryanodine on [Ca”],; (b) illustrates the effect of 1 PM ryanodine on 
a spontaneous cell bathed in a nominally Car+-free solution. Applica- 
tion of ryanodine and nominally Car’-free solution are indicated by 
the solid bars. Ordinates denote the ratio of fluorescence intensity 
measured at 350/380 nm, abscissae show time in seconds. Temperature 
33v. 
tions are consistent with the hypothesis that these cul- 
tured human myometrial cells possess a caffeine-sensi- 
tive, IP,-dependent intracellular Ca2’ release mecha- 
nism (I-CICR). This data also shows that caffeine has 
no Ca” mobilising characteristics and indicates that 
these cells do not possess the classical ryanodine-sensi- 
tive intracellular Ca2+ store. 
At low concentrations (C 10 PM) ryanodine binds to 
the open Ca2’ channel of the Ca2+-induced Ca” release 
protein of skeletal and cardiac muscle and maintains the 
channel in the open state [5]. Ryanodine dissociates 
from the channels slowly, and consequently Ca2+ is lost 
from the stores despite the activity of Ca”-ATPase 
driven pumps. At high concentrations (2 20 PM) ryan- 
odine is capable of inhibiting the Ca2’ channels of the 
release protein, by firstly activating the channel which 
then slowly closes as it reaches a more stable configura- 
tion [15]. The present experiments how that ryanodine 
can reversibly affect the release of Ca2’ from internal 
stores. Assuming that this effect of ryanodine is not a 
nonspecific toxic effect, it suggests that there are recep- 
tors for ryanodine on the internal membranes of these 
cells and that activation leads to an opening of Ca2+ 
channels on the sarcoplasmic reticulum resulting in the 
release of stored Ca2+. 
The R-CICR release channels in skeletal and cardiac 
muscle have been isolated and their structures deter- 
mined [2,1618]. Although there is a great deal of simi- 
larity between the proteins, specific differences in both 
structure and function have been noted [19]. This has 
led to the classification of the proteins as Rl-CICR in 
striated muscle and RZCICR in cardiac muscle. The 
structural differences between Rl- and RZCICR are 
probably related to their different means of activating 
the Ca2+ release mechanisms. For example, the Rl- 
CICR system is linked to the voltage sensor on the 
T-tubular membrane while the RZCICR mechanism is 
not. A third type of ryanodine receptor protein (R3- 
CICR) has been identified recently in mink lung epithe- 
lial cells [20] and in restricted areas of the rabbit brain 
[21]. Using a cDNA probe for the brain ryanodine re- 
ceptor it was found that an RNA species of similar size 
hybridised in many tissues containing smooth muscle, 
including the uterus [21]. The consequences of the alter- 
ations in the structure of the R3-CICR system are at 
present unclear. However, in the mink lung epithelial 
cells, this R3-CICR system does not appear to be caf- 
feine-sensitive [20]. 
In conclusion, it would appear that these cultured 
human myometrial cells possess an IP,-dependent intra- 
cellular Ca2’ release mechanism (I-CICR) and, in addi- 
tion, may have a second intracellular system which ap- 
pears to be ryanodine-sensitive. The caffeine sensitivity 
of this system remains to be established. The role of this 
second Ca2’ storage system in the human myometrium 
is presently unknown. This novel ryanodine-sensitive 
system may be similar to the R3-CICR system described 
in mink lung epithelial cells and involve the protein 
sequenced from rabbit brain. If this R3-CICR system 
were to occur in other tissues, care must be exercised in 
using methylxanthines to diagnose the presence of a 
R-CICR or eliminate R-CICR from the cellular re- 
sponse, for example in order to investigate IP,-induced 
Ca” release. 
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